Items where authors include "Morgan, G.J."

Export as [feed] Atom [feed] RSS
Number of items: 12.

Article

Jackson, G.H., Pawlyn, C., Cairns, D.A. et al. (20 more authors) (2021) Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI+): Interim analysis of an open-label randomised controlled trial. PLOS Medicine, 18 (1). e1003454. ISSN 1549-1277

Spink, C.F., Keen, L.J., Mensah, F.K. et al. (3 more authors) (2006) Association between non-Hodgkin lymphoma and haplotypes in the TNF region. British Journal of Haematology, 133 (3). pp. 293-300. ISSN 0007-1048

Lightfoot, T.J., Skibola, C.F., Willett, E.V. et al. (7 more authors) (2005) Risk of non-Hodgkin lymphoma associated with polymorphisms in folate-metabolizing genes. Cancer Epidemiology Biomarkers & Prevention, 14 (12). pp. 2999-3003. ISSN 1055-9965

Willett, E.V., Skibola, C.F., Adamson, P. et al. (4 more authors) (2005) Non-Hodgkin's Lymphoma: obesity and energy homeostasis polymorphisms. British Journal of Cancer, 93 (7). pp. 811-816. ISSN 0007-0920

Willett, E.V., Smith, A.G., Dovey, G.J. et al. (3 more authors) (2004) Tobacco and alcohol consumption and the risk of non-Hodgkin lymphoma. Cancer Causes and Control, 15 (8). pp. 771-780. ISSN 0957-5243

Barrans, S.L., Evans, P.A.S., O’Connor, S.J.M. et al. (5 more authors) (2003) The t(14;18) is associated with germinal center-derived diffuse large B-cell lymphoma and is a strong predictor of outcome. Clinical Cancer Research, 9 (6). pp. 2133-2139. ISSN 1078-0432

Barrans, S.L., Carter, I., Owen, R.G. et al. (5 more authors) (2002) Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma. Blood, 99 (4). pp. 1136-1143. ISSN 0006-4971

Allan, J.M., Wild, C.P., Rollinson, S. et al. (7 more authors) (2001) Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapyinduced leukemia. Proceedings of the National Academy of Sciences, 98 (20). pp. 11592-11597. ISSN 0027-8424

Allan, J.M., Wild, C.P., Rollinson, S. et al. (7 more authors) (2001) Polymorphism in glutathione S-transferase is associated with susceptibility to chemotherapy-induced leukemia. Proceedings of the National Academy of Sciences of the United States of America, 98 (98). pp. 11592-11597. ISSN 0027-8424

Proceedings Paper

Jackson, G.H., Davies, F.E., Pawlyn, C. et al. (18 more authors) (2016) Lenalidomide is a highly effective maintenance therapy in myeloma patients of all ages; results of the Phase III Myeloma XI Study. In: Blood. 58th ASH Annual Meeting, 03-06 Dec 2016, San Diego, CA, USA. American Society of Hematology .

Pawlyn, C., Davies, F.E., Kaiser, M.F. et al. (18 more authors) (2016) Primary IMiD refractory myeloma; results from 3894 patients treated in the Phase III Myeloma XI Study. In: Blood. 58th ASH Annual Meeting, 03-06 Dec 2016, San Diego, CA, USA. American Society of Hematology .

Jackson, G.H., Davies, F.E., Pawlyn, C. et al. (18 more authors) (2016) Response adapted induction treatment improves outcomes for myeloma patients; results of the Phase III Myeloma XI Study. In: Blood. 58th ASH Annual Meeting, 03-06 Dec 2016, San Diego, CA, USA. American Society of Hematology .

This list was generated on Sun Mar 24 09:26:20 2024 GMT.